Skip to main content
Clinical Trials/ISRCTN65670698
ISRCTN65670698
Completed
未知

Randomised, double-blind, placebo-controlled clinical trial of trimethoprim-sulfamethoxazole as prophylaxis for opportunistic infections in human immunodeficiency virus (HIV)-infected post-natal Zambian women

niversity College London (UK)0 sites600 target enrollmentApril 22, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity College London (UK)
Enrollment
600
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/21281407 (added 31/10/2019)

Registry
who.int
Start Date
April 22, 2009
End Date
January 1, 2004
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity College London (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Women who have recently given birth
  • 2\. Aged 16 years or more
  • 3\. HIV\-seropositive at stage 2 or 3 of the World Health Organization (WHO) staging system for HIV infection
  • 4\. Evidence of residence at a permanent address in Lusaka
  • 5\. Willing to attend at two\-monthly intervals for follow\-up
  • 6\. Informed written or verbal consent

Exclusion Criteria

  • 1\. Current opportunistic infection or currently receiving co\-trimoxazole
  • 2\. History of sulphonamide allergy
  • 3\. Breast feeding women with premature babies
  • 4\. Advanced HIV\-disease or serious non\-HIV disease (i.e. unlikely to survive more than 2 weeks)

Outcomes

Primary Outcomes

Not specified

Similar Trials